Rankings
▼
Calendar
DAWN Q3 2020 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
DAWN
Day One Biopharmaceuticals, Inc.
$2B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$46,000
Operating Income
-$4M
Net Income
-$3M
EPS (Diluted)
$-0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$60,000
← FY 2020
All Quarters
Q4 2020 →
